Literature DB >> 26244758

A Comparison of Outcomes Following Laparoscopic and Open Hysterectomy With or Without Lymphadenectomy for Presumed Early-Stage Endometrial Cancer: Results From the Medical Research Council ASTEC Trial.

Maria Kyrgiou1, Anne-Marie Swart, Wendi Qian, Jane Warwick.   

Abstract

OBJECTIVES: Laparoscopic hysterectomy (LH) is increasingly used for the management of endometrial malignancy. Its benefits may be particularly pronounced as these women are more likely to be older or obese. The aim of this study was to determine whether outcomes for LH are comparable to the open hysterectomy (OH).
DESIGN: This was a prospective cohort study nested within the multicenter ASTEC (A Study in the Treatment of Endometrial Cancer) randomized controlled trial (1998-2005). POPULATION: Women with presumed early endometrial cancer were included.
METHODS: Laparoscopic hysterectomy was compared with OH with or without systematic lymphadenectomy. MAIN OUTCOME MEASURES: Overall survival, time to first recurrence, complication rates, and surgical outcomes were the main outcome measures.
RESULTS: Of 1408 women, 1309 (93%) received OH, and 99 (7%) had LH. LH was associated with longer operating time (median, LH 105 minutes [interquartile range (IQR), 60-150] vs OH 80 minutes [IQR, 60-95]; P < 0.001) but 50% shorter hospital stay (median, LH 4 days [IQR, 3-5] vs OH 6 days [IQR, 5-7]). The number of harvested lymph nodes was similar (median, LH 13 [IQR, 10-16] vs OH 12 [IQR, 11-13]; P = 0.67). LH had fewer intraoperative and postoperative adverse events (9% difference, LH 21% vs OH 30%; borderline significance; P = 0.07). The rate of conversion to laparotomy for the LH group was high (27%). The median follow-up was 37 months. After adjusting for significant prognostic factors, the hazard ratio for overall survival in those who underwent LH compared with those who underwent OH was 0.67 (95% confidence interval, 0.31-1.43) (P = 0.30).
CONCLUSIONS: Laparoscopic hysterectomy for early endometrial cancer is safe. Although it requires longer operating time it is associated with shorter hospital stay and favorable morbidity profile. Further studies are required to assess the long-term safety.

Entities:  

Mesh:

Year:  2015        PMID: 26244758     DOI: 10.1097/IGC.0000000000000521

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

2.  Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedure.

Authors:  Thomas Papathemelis; Helen Oppermann; Stella Grafl; Michael Gerken; Armin Pauer; Sophia Scharl; Anton Scharl; Elisabeth Inwald; Atanas Ignatov; Olaf Ortmann; Monika Klinkhammer-Schalke; Alexander Hein; Matthias W Beckmann; Michael P Lux
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-04       Impact factor: 4.553

3.  Comparison of outcomes following laparoscopic and open hysterectomy with pelvic lymphadenectomy for early stage endometrial carcinoma.

Authors:  Xu Cong Ruan; Wai Loong Wong; Hui Qing Yeong; Yong Kuei Timothy Lim
Journal:  Singapore Med J       Date:  2018-07       Impact factor: 1.858

4.  Survival Analysis in Endometrial Carcinomas by Type of Surgical Approach: A Matched-Pair Study.

Authors:  Pluvio J Coronado; Agnieszka Rychlik; Laura Baquedano; Virginia García-Pineda; Maria A Martínez-Maestre; Denis Querleu; Ignacio Zapardiel
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

Review 5.  Hormone replacement therapy for women previously treated for endometrial cancer.

Authors:  Katharine A Edey; Stuart Rundle; Martha Hickey
Journal:  Cochrane Database Syst Rev       Date:  2018-05-15

6.  Safety of total laparoscopic modified radical hysterectomy with or without lymphadenectomy for endometrial cancer.

Authors:  Masakazu Kitagawa; Kayo Katayama; Atsuko Furuno; Yukiko Okada; Asuna Yumori; Hideya Sakakibara; Hiroyuki Shigeta; Hiroshi Yoshida
Journal:  Gynecol Minim Invasive Ther       Date:  2016-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.